Allenex enter agreement on conditions for loan refinancing

Allenex AB enters agreement for refinancing of existing loans according to the
following:

As stated earlier, Allenex and other companies within the group have a bank loan
of 30 msek and a convertible 31 msek, due for payment June 30th2013. A
refinancing agreement is now ready. The above loans and another bank loan of 27
msek are paid, financed by new loans of 90 msek. The new loans are provided by
Allenex main bank Danske Bank to the amount of 70 msek, and by Allenex main
owners FastPartner AB and Mohammed Al Amoudi, to the amount of 20 msek. The
loans have a term of 3 years and the average interest rate on the new loans (90
million) is currently 5.8%. Refinancing requires the customary written
contracts.

For more information please contact:

Anders Karlsson, CEO Allenex AB, and ph.: +4670-918 00 10, e-mail:
anders.karlsson@allenex.se

Allenex AB discloses the information provided herein pursuant to the Securities
Markets Act and /or the Financial Instruments Trading Act. The information was
submitted for publication on April 25, 2013, at 08.30 CET. Allenex is a life
science-company that develops, manufacture, market and sell products for safer
transplants of organs and bone marrow on the global market. Allenex is listed on
NASDAQ OMX Stockholm Small Cap (ticker: ALNX). 54 persons are employed in the
Allenex group.